YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USA
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), announced that the FDA has advised the Company that it may now enroll patie…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM), announced that the FDA has advised the Company that it may now enroll patie…
No one wants it but it keeps piling up. Waste is almost a regenerative resources, but not one that is usually seen in a…
Der hervorragende nationale und internationale Ruf der Bremer Produktionswissenschaften hat auch personelle Konsequenze…
With gastight muffle for heat treatment processes under protective gas atmosphere (H2) up to 1050 °C. Useful chamber 60…
Amedrix GmbH announces that High-Tech Gruenderfonds (HTGF) and Life Science Fonds Esslingen jointly invested a total of…
2009 was a pivotal year for Galenica. The Group made huge investments to prepare for the future: two strategically impor…
Effective immediately, Hamburg's TIG Group will be cooperating with the Finnish company Ehovoc Oy. For 10 years now Ehov…
EBS Technology GmbH, based in Kleinmachnow, announces the completion of its second financing round raising 3 million Eur…
• China searches for economic and ecological solutions for dealing with large volumes of sewage sludge • New regulatio…
. - Strategic alliance with CHDI aimed at accelerating efforts to develop drugs against Huntington's disease - Entail…